$AMC [ELEVATED] 60/100
$SMCI [ELEVATED] 60/100
$RKLB [NORMAL] 60/100
$RGTI 57/100
$URA 57/100
$MSTR 56/100
$GME 56/100
$HOOD 56/100
$DKNG 54/100
$PL 54/100
$SOFI 54/100
$RIVN 53/100
$PLTR 50/100
$CLOV 50/100
$INTC 50/100
$TSLA 49/100

Volatility signal, not direction.

$PL [NORMAL] 60/100
$ASTS [NORMAL] 60/100
$DKNG [NORMAL] 59/100
$RKLB 58/100
$AMC 56/100
$INTC 55/100
$PLTR 54/100
$TSLA 54/100
$GME 53/100
$URA 52/100
$SOFI 52/100
$RIVN 51/100
$RGTI 51/100
$HOOD 50/100
$MSTR 50/100
$CLOV 49/100

Volatility signal, not direction.

$SMCI [ELEVATED] 66/100
$ASTS [ELEVATED] 64/100
$GME [ELEVATED] 61/100
$PL 60/100
$IONQ 58/100
$RGTI 57/100
$AMC 56/100
$RIVN 54/100
$MSTR 54/100
$INTC 53/100
$TSLA 53/100
$URA 52/100
$PLTR 52/100
$HOOD 52/100
$SOFI 50/100
$CLOV 49/100

Volatility signal, not direction.

$GME [ELEVATED] 62/100
$PL [NORMAL] 60/100
$ASTS [NORMAL] 58/100
$PLTR 55/100
$HOOD 53/100
$DKNG 53/100
$CLOV 53/100
$TSLA 53/100
$SOFI 53/100
$RKLB 52/100
$MSTR 52/100
$URA 52/100
$RIVN 51/100
$RGTI 50/100
$INTC 49/100
$IONQ 49/100

Volatility signal, not direction.

$PL [ELEVATED] 66/100
$GME [ELEVATED] 63/100
$RKLB [ELEVATED] 62/100
$HOOD 61/100
$ARM 59/100
$URA 58/100
$ASTS 58/100
$IONQ 58/100
$RIVN 57/100
$TSLA 56/100
$CLOV 56/100
$MSTR 54/100
$INTC 54/100
$PLTR 54/100
$SOFI 52/100
$RGTI 52/100

Volatility signal, not direction.

$INTC [ELEVATED] 69/100
$ARM [ELEVATED] 69/100
$AMC [NORMAL] 60/100
$RIVN 60/100
$ASTS 60/100
$URA 60/100
$DKNG 60/100
$HOOD 59/100
$CLOV 59/100
$MSTR 57/100
$TSLA 57/100
$SOFI 55/100
$RGTI 54/100
$PLTR 51/100

Volatility signal, not direction.

When doctors used this AI prompt, high-risk patients had fewer flu ER trips Patients whose doctors completed the flu insight were 1.89 times more likely to get vaccinated, a shift tied to fewer acute events in COPD and CHF.

#CLOV Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients

www.stocktitan.net/news/CLOV/primary-care-p...

UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives Clover Health (Nasdaq: CLOV) is live on Kno2 and participating in CMS-aligned interoperability initiatives, enabling real-time, patient-directed responses for clinical and claims data using FHIR (USCDI v3) standards.Participation is powered by Counterpart Health infrastructure and Kno2 routing; live demonstrations will run March 10–12, 2026 at HIMSS 2026.

#CLOV UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives

www.stocktitan.net/news/CLOV/updated-moving...

Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network Clover Health (Nasdaq: CLOV) announced it is the first payer live on a CMS Aligned Network and TEFCA for patient-directed requests, enabling real-time responses to clinical and claims data in standardized FHIR (USCDI v3) formats. Counterpart Health powers the underlying infrastructure and Kno2 routes secure requests across the network.The milestone enables authenticated Medicare members to request and receive structured clinical and claims data in real time, and Clover, Kno2, and Counterpart will demonstrate an end-to-end response at HIMSS 2026, March 10–12 at Kno2 booth #12720.

#CLOV Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network

www.stocktitan.net/news/CLOV/clover-health-...

after earnings

#INTU Intuit = -4%
#NTAP NetApp = +2%
#DELL Dell = +12%
#MARA Marathon Digital = +16%
#CLOV Clover Health = -1%
#AMBA Ambarella = -12%
#MNST Monster Beverage = -2%
#CRWV CoreWave = -11%
#RKLB Rocket Lab = -5%

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance Clover Health (Nasdaq: CLOV) reported full year 2025 results and provided 2026 guidance. Key 2025 results: $1.924B total revenues (+40% YoY), Medicare Advantage membership 113,803 (+38% YoY), GAAP net loss $85.5M, and Adjusted EBITDA $21.7M. For 2026 the company guides 154,000–158,000 average MA members, total revenues of $2.81B–$2.92B, Consolidated Gross profit $470M–$510M, Adjusted EBITDA $50M–$70M, and GAAP Net Income $0M–$20M.Management cited improving cohort economics, Clover Assistant-driven care, and membership scaling as drivers toward first full-year GAAP profitability in 2026.

#CLOV Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance

www.stocktitan.net/news/CLOV/clover-health-...

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #CX 128.3x
2. #FAST 37.9x
3. #SSRM 16.4x
4. #CLOV 15.9x
5. #IBRX 10.0x

#OptionFlow #OptionsTrading #Trading

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#RKT, #LQDA, #CLOV, #SRAD, #ASST

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CX, #SSRM, #CLOV, #IBRX, #SBET

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#ETSY, #TEN, #ACDC, #DOC, #CLOV

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CMS, #HNRG, #ATI, #CLOV, #OGI

#OptionFlow #OptionsTrading #Trading

Most Searched, Wednesday November 5, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Nov 5th - #CMBM #TE #LAES #CLOV #GGB #NVTS #ALIT #BHVN #BTBT #FUBO #RXRX #BITF #BBAI #DNN #SLDP #PLUG #USAR #OUST #ONDS #CRML - More: crystalequityresearch.com/most-searche... - #smallcap

#CLOV Clover Health Reports Third Quarter 2025 Results

www.stocktitan.net/news/CLOV/clover-health-...

Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations Counterpart Health (Nasdaq: CLOV) released a whitepaper (Oct 30, 2025) showing its Counterpart Assistant (CA) tech helped primary care teams in high Area Deprivation Index neighborhoods detect chronic disease earlier and reduce hospital use.Key results: diagnosis rates were higher for diabetes (+75%), CKD (+89%), CHF (+89%) and COPD (+70%); CKD detected at average Stage 2 vs 3A; diabetes A1C averaged 6.8% vs 7.1%; inpatient hospitalizations fell -7.6% to -21.2% and 30-day readmissions fell -11.5% to -20.8% across four diseases.

#CLOV Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations

www.stocktitan.net/news/CLOV/primary-care-p...

Another 120 stocks up >10% today #CLOV #CIFR #LAZR #CRML #OPEN #TMQ #FLNC #STEM #HUT #GRAL #LTBR #ABAT

All powered by a softer-than-expected September CPI report and better-than-expected October S&P Global Composite PMI report.

Good stuff for the bulls.

Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or

#CLOV Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners

www.stocktitan.net/news/CLOV/counterpart-he...

Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027 Clover Health Investments,

#CLOV Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027

www.stocktitan.net/news/CLOV/clover-health-...

Most Searched, Wednesday October 1, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Oct 1st - #AKAN #NVTS #ONDS #PTON #RIG #RXRX #CLOV #HIVE #HCTI #GDRX #RZLBV #DNN #PLUG #WRD #TLRY #EXK #LUNR #LAC #HUT - More: crystalequityresearch.com/most-searche... - #smallcap

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #CLOV 23.0x
2. #VALE 19.4x
3. #ABTC 17.4x
4. #AES 16.2x
5. #CSIQ 9.7x

#OptionFlow #OptionsTrading #Trading

Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way Clover Health (NASDAQ:CLOV) CEO Andrew Toy testified before the U.S. House Committee on Energy and Commerce Subcommittee on Health regarding AI's role in healthcare transformation. The testimony highlighted how Clover Assistant, the company's AI platform, is delivering measurable improvements in patient care and cost reduction.Key achievements include diagnosing diabetes 3 years earlier and chronic kidney disease 1.5 years earlier than traditional methods. For patients with congestive heart failure, the platform has demonstrated 18% fewer hospitalizations and 25% fewer readmissions, while COPD patients experienced 15% fewer hospitalizations and 18% lower 30-day readmissions.The platform serves thousands of healthcare providers across multiple states, focusing on democratizing high-quality care by bringing sophisticated care-coordination capabilities to independent physicians, particularly in rural and underserved communities.

#CLOV Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way

www.stocktitan.net/news/CLOV/clover-health-...

Most Searched, Wednesday August 6, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Aug 6th - #GO #FUN #CLOV #GV #ONDS #RIG #BTAI #BTBT #DNN #WRD #UUUU #SBET #QUBT #OPEN #LUNR #EVH #ESPR #CGAU #CERS #CLSK - More: crystalequityresearch.com/most-searche... - #smallcap

after earnings

#AMD AMD = -6%
#SMCI SuperMicro = -16%
#SNAP Snap = -15%
#CLOV Clover Health = -12%
#RIVN Rivian = -4.5%
#MTCH Match Group = +7%
#LCID Lucid = -8.5%
#AMGN Amgen = -1%

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth Clover Health (NASDAQ:CLOV) reported strong Q2 2025 results with significant growth in key metrics. The company achieved Medicare Advantage membership of 106,323, up 32% year-over-year, and total revenues of $478 million, a 34% increase. Despite posting a GAAP net loss of $11 million, Clover demonstrated operational efficiency with Adjusted EBITDA and Adjusted Net income both at $17 million.The company's technology-first model showed clinical success, with their AI-driven Clover Assistant correlating to 15% lower hospitalizations and 18% lower readmissions for COPD patients. Management updated 2025 guidance, increasing Medicare Advantage membership expectations to 104,000-108,000 while maintaining revenue guidance of $1.8-1.875 billion and improving Adjusted SG&A projections.

#CLOV Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth

www.stocktitan.net/news/CLOV/clover-health-...

Groundbreaking Study: AI Assistant Cuts COPD Hospital Readmissions by 18%, Transforms Patient Care New clinical data reveals how AI-powered physician platform improves COPD care with 75% better diagnosis rates and reduced hospitalizations. See full outcome metrics.

#CLOV Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease

www.stocktitan.net/news/CLOV/primary-care-p...